FindTrial
Sign In

CT and MRI findings in COVID associated Rhino-Orbito-Cerebral Mucormycosis

Imaging spectrum in COVID associated Rhino-Orbital-Cerebral Mucormycosis (ROCM)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038598
Enrollment
100
Registered
2021-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B461- Rhinocerebral mucormycosis

Interventions

None listed

Sponsors

Department of Radiodiagnosis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive individuals admitted in AIIMS, Raipur i. With history suggestive of COVID 19 infection. ii. With probable/proven Rhino-orbito-cerebral mucormycosis. iii. Whose CT scan / MRI scans are available.

Exclusion criteria

Exclusion criteria: Possible (suspected) cases of Rhino-orbito-cerebral mucormycosis

Design outcomes

Primary

MeasureTime frame
To characterize the CT scan and multi-parametric MRI findings in patients of COVID associated rhino-orbito-cerebral mucormycosis (ROCM) and its complications.Timepoint: NIL (As this is an observational study, analysis of CT/MRI images of the patient will be conducted only once. So no time points could be specified.)—

Secondary

MeasureTime frame
To correlate imaging findings with the surgical, histopathological or microbiological findings wherever possible.Timepoint: NIL—

Countries

India

Contacts

Public ContactChitti Srinath Reddy

All India Institute of Medical Sciences, Raipur

srinathreddychitti@gmail.com9560371652

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026